Vicks Formula 44dm Liquid
NDC Package 69423-811-12
Package Information
Vicks Formula 44dm (acetaminophen, dextromethorphan hbr, chlorpheniramine maleate) liquids is • take only as directed • only use the dose cup provided • do not exceed 4 doses per 24 hrs adults & children 12 yrs & over30 mL every 6 hrschildren 4 to under 12 yrsask a doctorchildren under 4 yrsdo not use. This formulation utilizes a liquid delivery system. Marketed by Procter & Gamble Manufacturing Company, this product is identified by NDC 69423-811 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1292342 - acetaminophen 650 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 30 MG in 15 mL Oral Solution
- RxCUI: 1292342 - acetaminophen 43.3 MG/ML / chlorpheniramine maleate 0.267 MG/ML / dextromethorphan hydrobromide 2 MG/ML Oral Solution
- RxCUI: 1292342 - acetaminophen 650 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 30 MG per 15 ML Oral Solution
- RxCUI: 1292342 - APAP 43.3 MG/ML / chlorpheniramine maleate 0.267 MG/ML / dextromethorphan HBr 2 MG/ML Oral Solution
- RxCUI: 1292342 - APAP 43.3 MG/ML / Chlorpheniramine Maleate 0.267 MG/ML / Dextromethorphan Hydrobromide 2 MG/ML Oral Solution
Clinical Specifications
- Histamine H1 Receptor Antagonists - [MoA] (Mechanism of Action)
- Histamine-1 Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 69423 - Procter & Gamble Manufacturing Company
- 69423-811 - Vicks Formula 44dm
- 69423-811-12 - 354 mL in 1 BOTTLE, PLASTIC
- 69423-811 - Vicks Formula 44dm
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69423-811-12 identifies a specific commercial package of 354 ml in 1 bottle, plastic of Vicks Formula 44dm Nighttime Cough And Cold, a human over the counter drug labeled by Procter & Gamble Manufacturing Company. This liquid is formulated for oral use and contains acetaminophen; chlorpheniramine maleate; dextromethorphan hydrobromide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Procter & Gamble Manufacturing Company on January 25, 2021. The current certification is valid through December 31, 2026.
How is this Procter & Gamble Manufacturing Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69423081112. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.